DK207675A - Fremgangsmade til fremstilling af 3-(5-nitromidazol-2-yl)-pyrazolo/3,4-/pyrimidinforbindelser - Google Patents

Fremgangsmade til fremstilling af 3-(5-nitromidazol-2-yl)-pyrazolo/3,4-/pyrimidinforbindelser

Info

Publication number
DK207675A
DK207675A DK207675A DK207675A DK207675A DK 207675 A DK207675 A DK 207675A DK 207675 A DK207675 A DK 207675A DK 207675 A DK207675 A DK 207675A DK 207675 A DK207675 A DK 207675A
Authority
DK
Denmark
Prior art keywords
nitromidazol
pyrazolo
preparing
procedure
pyrimidine compounds
Prior art date
Application number
DK207675A
Other languages
Danish (da)
English (en)
Inventor
H Friedman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK207675A publication Critical patent/DK207675A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • C07D233/94Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK207675A 1974-05-13 1975-05-12 Fremgangsmade til fremstilling af 3-(5-nitromidazol-2-yl)-pyrazolo/3,4-/pyrimidinforbindelser DK207675A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46925674A 1974-05-13 1974-05-13
US05/545,852 US4001230A (en) 1974-05-13 1975-01-31 3-(5-Nitroimidazol-2-yl)pyrazolo[3,4-d]pyrimidine compounds

Publications (1)

Publication Number Publication Date
DK207675A true DK207675A (da) 1975-11-14

Family

ID=27042704

Family Applications (1)

Application Number Title Priority Date Filing Date
DK207675A DK207675A (da) 1974-05-13 1975-05-12 Fremgangsmade til fremstilling af 3-(5-nitromidazol-2-yl)-pyrazolo/3,4-/pyrimidinforbindelser

Country Status (14)

Country Link
US (1) US4001230A (es)
JP (1) JPS511492A (es)
AR (2) AR204665A1 (es)
AU (1) AU8102575A (es)
BR (1) BR7502919A (es)
DD (1) DD120442A5 (es)
DE (1) DE2521046A1 (es)
DK (1) DK207675A (es)
ES (1) ES437599A1 (es)
FR (1) FR2270880A1 (es)
IL (1) IL47259A0 (es)
NL (1) NL7505520A (es)
PH (1) PH11588A (es)
SE (1) SE7505439L (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075222A (en) * 1975-03-14 1978-02-21 Eli Lilly And Company 3-(5-Nitro-2-imidazolyl)pyrazoles
DE2827351A1 (de) * 1978-06-22 1980-01-10 Basf Ag 2-substituierte 1-alykl-nitroimidazole und verfahren zur herstellung von 2-substituierten 1-alkyl-nitroimidazolen
DE4129488A1 (de) * 1991-09-05 1993-03-11 Vaw Ver Aluminium Werke Ag Verfahren zur ueberfuehrung von schadstoffbelasteten rueckstaenden aus verbrennungsanlagen in eine feste, unbedenklich deponierbare form
US20030199525A1 (en) * 2002-03-21 2003-10-23 Hirst Gavin C. Kinase inhibitors
GB0610242D0 (en) * 2006-05-23 2006-07-05 Novartis Ag Organic compounds
US20110224223A1 (en) 2008-07-08 2011-09-15 The Regents Of The University Of California, A California Corporation MTOR Modulators and Uses Thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL128809C (es) * 1966-06-18
BE758050A (fr) * 1969-10-28 1971-04-27 Geigy Ag J R Derives 5-nitro-furyliques et medicaments contenant de tels composes
AR205429A1 (es) * 1971-04-27 1976-05-07 Ciba Geigy Ag Procedimiento para la elaboracion de nuevos derivados de 4-amino - 3-(5-nitro- 2 -furil)-1-metil - 1h - pirazol-(3,4-ol)-pirimidina
PL91799B1 (es) * 1972-04-01 1977-03-31

Also Published As

Publication number Publication date
IL47259A0 (en) 1975-12-31
AR205234A1 (es) 1976-04-12
JPS511492A (en) 1976-01-08
US4001230A (en) 1977-01-04
BR7502919A (pt) 1976-03-23
FR2270880A1 (es) 1975-12-12
DD120442A5 (es) 1976-06-12
ES437599A1 (es) 1977-01-16
DE2521046A1 (de) 1975-11-27
AR204665A1 (es) 1976-02-20
PH11588A (en) 1978-03-31
SE7505439L (sv) 1975-11-14
AU8102575A (en) 1976-11-11
NL7505520A (nl) 1975-11-17

Similar Documents

Publication Publication Date Title
DK298176A (da) Fremgangsmade til fremstilling af 1,4-dihydropyrinderivater
DK442476A (da) Fremgangsmade til fremstilling af pyrimidinforbindelser
DK135376B (da) Fremgangsmåde til fremstilling af piperazinylquinazolin-forbindelser.
DK135711B (da) Analogifremgangsmåde til fremstilling af hidtil ukendte, hjerteaktive substituerede fenoxyisopropanolaminer.
DK490775A (da) Fremgangsmade til fremstilling af eventuelt substituerede 1,2,3,5-tetrahydroimidazo(2,1-b)-quinazolin-2-oner
DK243676A (da) Fremgangsmade til fremstilling af pyrrolforbindelser
DK179675A (da) Fremgangsmade til fremstilling af 6-amino-5-r3-2,4-diaminopyrimidin-3-oxider
DK164476A (da) Fremgangsmade til fremstilling af piperazinylpyrazinforbindelser
DK134551C (da) Fremgangsmade til fremstilling af 1,2,4-triazolderivater
DK136656B (da) Analogifremgangsmåde til fremstilling af substituerede piperazinyliminorifamyciner.
DK566977A (da) Fremgangsmaade til fremstilling af polyenforbindelser
DK356375A (da) Fremgangsmade til fremstilling af 2-thiol-4,5-diphenyloxazol-s-derivater
DK301277A (da) Fremgangsmade til fremstilling af substituerede 2,6-methano-2h-1-benzoxociner
DK207675A (da) Fremgangsmade til fremstilling af 3-(5-nitromidazol-2-yl)-pyrazolo/3,4-/pyrimidinforbindelser
DK390975A (da) Fremgangsmade til fremstilling af omega-nor-cycloalkyl-13,14-dehydroprostaglandiner
DK247877A (da) Fremgangsmade til fremstilling af klavamforbindelser
DK131633C (da) Fremgangsmade til fremstilling af 3-(17beta-4-androsten-3-on-17beta-yl)-propiolacton
DK219776A (da) Fremgangsmade til fremstilling af 1,2-benzothiazin-oxadiazolforbindelse
DK475376A (da) Fremgangsmade til fremstilling af 2,9-dioxatricyclo/4,3,1,03,7/decan-forbindelser
DK280376A (da) Fremgangsmade til fremstilling af 1-acyl-1,2,3,4-tetrahydro-6-quinoliner
DK505275A (da) Fremgangsmade til fremstilling af 7,7-diphenylhexahydro-1,4-oxazepiner
DK138499B (da) Fremgangsmåde til fremstilling af 11beta-hydroksy-18-alkyløstranforbindelser.
DK137924C (da) Fremgangsmaade til fremstilling af 1,4-dihydroquinoliner
DK348575A (da) Fremgangsmade til fremstilling af 9,11,15-trihydroxy-13,14-dehydro-prostaglandiner
DK132661C (da) Fremgangsmade til fremstilling af 17-acylestere af 17alfa,21-dihydroxysteroider af pregnanrekken